Distigmine bromide (Ubretid) for the prevention of urinary retention after vaginal hysterectomy.
D000328:Adult; D002219:Carbamates / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects*; D007273:Injections, Intramuscular; D008744:Methylamines / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D014546:Urinary Catheterization; D014552:Urinary Tract Infections / Q000517:prevention & control; D014555:Urination Disorders / Q000517:prevention & control*
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D008744:Methylamines; D011726:Pyridinium Compounds